Earlier report examining the expression levels of membrane proteins showed SLC3A2 was markedly up-regulated in GC cells and GC tumor tissues and may serve as a potential biomarker for molecular imaging-based detection of GC [9]. This evidence concerns the gene SLC3A2 and neoplasm.